Abstract
Delayed ejaculation (DE) is a challenging disorder to treat. Many clinicians are not comfortable dealing with DE due to a lack of treatment approaches supported by evidence-based medicine. In this review, we discuss the most common treatments and the latest studies that support each DE treatment. The goal of our review is to help clinicians identify and treat patients who present with this disorder. An integrative approach using medications, penile vibratory stimulation, and sexual counseling is important for successful treatment of DE. We propose an algorithm for DE treatment to help guide clinicians. However, an individualized treatment plan should be developed for each unique case due to the multifactorial etiology of DE.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Bronner G, Ben-Zion IZ. Unusual masturbatory practice as an etiological factor in the diagnosis and treatment of sexual dysfunction in young men. J Sex Med. 2014;11(7):1798–806. This was an interesting approach to obtaining sexual histories around masturbation and idiopathic styles.
Mulhall JP, Hsiao W. Chapter 9—delayed ejaculation and orgasm. In: Nelson CJ, Brock D, Dean RC, editors. Men’s sexual health and fertility: a clinician’s guide. New York: Springer; 2014. p. 145–58. The chapter on delayed ejaculation was a good review of the literature and outlined treatments.
Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7(4 Pt 2):1668–86.
Aukst-Margetic B, Margetic B. An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(5):754–6.
Shin D, Spitz A. The evaluation and treatment of delayed ejaculation. Sex Med Rev. 2014;2(3–4):121–33. This is another excellent review of the topic of DE and the treatments.
Yager J. Bethanechol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: case report. J Clin Psychiatry. 1986;47(4):210–1.
Lue TF, Basson R, Rosen R, Guiliano F, Khoury S, Montorsi F. Sexual medicine: sexual dysfunctions in men and women. Plymouth: Health Publications; 2004.
Association, A.P. Diagnostic and statistical manual of mental disorders. Fifthth ed. Washington: American Psychiatric Publishing; 2013. p. 423–9.
Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, et al. Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005;2(3):358–67.
Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005;2(4):492–7.
Rowland DL, Keeney C, Slob AK. Sexual response in men with inhibited or retarded ejaculation. Int J Impot Res. 2004;16(3):270–4.
Nathan SG. The epidemiology of the DSM-III psychosexual dysfunctions. J Sex Marital Ther. 1986;12(4):267–81.
Richardson D, Nalabanda A, Goldmeier D. Retarded ejaculation—a review. Int J STD AIDS. 2006;17(3):143–50.
Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav. 1990;19(4):389–408.
Georgiadis JR, Reinders AA, Van der Graaf FH, Paans AM, Kortekaas R. Brain activation during human male ejaculation revisited. Neuroreport. 2007;18(6):553–7.
Porst H, Buvat J, Standards Committee of the International Society for Sexual Medicine, editors. Standard practice in sexual medicine. Malden, Mass.; Oxford: Blackwell Pub.; 2006.
McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2004;1(1):58–65.
Butcher M, et al. Delayed ejaculation remains a recalcitrant condition: results of a SMSNA survey. 20th Annual Fall Scientific Meeting of SMSNA, November 20–23, 2014 Program Book, 2014(Abstract 041): p. 70.
Perelman MA. A new combination treatment for premature ejaculation: a sex therapist’s perspective. J Sex Med. 2006;3(6):1004–12.
Binik YM, Hall KSK. Chapter 6: delayed ejaculation. In: Perelman MA, editor. Principles and practice of sex therapy. Fifthth ed. New York: The Guilford Press; 2014. p. 138–55. The chapter reviewed sexual dysfunction and included DE which was very helpful.
Waldinger MD. Toward evidence-based genetic research on lifelong premature ejaculation: a critical evaluation of methodology. Korean J Urol. 2011;52(1):1–8.
Gregoire A. ABC of sexual health: assessing and managing male sexual problems. BMJ. 1999;318(7179):315–7.
Minderhoud JM, Leemhuis JG, Kremer J, Laban E, Smits PM. Sexual disturbances arising from multiple sclerosis. Acta Neurol Scand. 1984;70(4):299–306.
Jannini EA, Simonelli C, Lenzi A. Disorders of ejaculation. J Endocrinol Invest. 2002;25(11):1006–19.
Corona G, Ricca V, Bandini E, Mannucci E, Lotti F, Boddi V, et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 2009;6(5):1259–69.
Kiev A, Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry. 1997;58(4):146–52.
Althof SE. Psychological interventions for delayed ejaculation/orgasm. Int J Impot Res. 2012;24(4):131–6.
Perelman M. Idiosyncratic masturbation patterns: a key unexplored variable in the treatment of retarded ejaculation by the practicing urologist. J Urol. 2005;173:340. Abstract 1254.
Teloken P, Nelson C, Mullhall J. Outcomes with medical treatment of secondary delayed orgasm proposal of a clinical care pathway. Journal of Urology. 2012;187(4, Supplement 1496):e606.
Butcher M, et al. How is delayed ejaculation defined and treated in North America? Andrology. 2015.
McMahon CG, Jannini E, Waldinger M, Rowland D. Standard operating procedures in the disorders of orgasm and ejaculation. J Sex Med. 2013;10(1):204–29. This was an excellent review of the pathophysiology, etioloies and treatments for DE.
McMahon CG. Management of ejaculatory dysfunction. Intern Med J. 2014;44(2):124–31.
Kendirci M, Hellstrom WJ. Intranasal apomorphine. IDrugs. 2004;7(5):483–8. Nastech Pharmaceutical.
Taylor MJ. Strategies for managing antidepressant-induced sexual dysfunction: a review. Curr Psychiatry Rep. 2006;8(6):431–6.
Schweitzer I, Maguire K, Ng C. Sexual side-effects of contemporary antidepressants: review. Aust N Z J Psychiatry. 2009;43(9):795–808.
Kruger TH, Haake P, Haverkamp J, Krämer M, Exton MS, Saller B et al. Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol. 2003;179(3):357–65.
Wittstock M, Benecke R, Dressler D. Cabergoline can increase penile erections and libido. Neurology. 2002;58(5):831.
Kruger TH, Hartmann U, Schedlowski M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol. 2005;23(2):130–8.
DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry. 2005;66(7):844–8.
Labbate LA, Grimes JB, Hines A, Pollack MH. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997;9(4):241–5.
Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 1998;59(3):112–5.
Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004;65(1):62–7.
Safarinejad MR. Midodrine for the treatment of organic anejaculation but not spinal cord injury: a prospective randomized placebo-controlled double-blind clinical study. Int J Impot Res. 2009;21(4):213–20.
Veening JG, de Jong TR, Waldinger MD, Korte SM, Olivier B. The role of oxytocin in male and female reproductive behavior. Eur J Pharmacol. 2014;753:209–28.
Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M. The hormonal control of ejaculation. Nat Rev Urol. 2012;9(9):508–19.
Filippi S, Vannelli GB, Granchi S, Luconi M, Crescioli C, Mancina R et al. Identification, localization and functional activity of oxytocin receptors in epididymis. Mol Cell Endocrinol. 2002;193(1–2):89–100.
Vignozzi L, Filippi S, Luconi M, Morelli A, Mancina R, Marini M, et al. Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology. 2004;145(4):1823–34.
Burri A, Heinrichs M, Schedlowski M, Kruger TH. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. Psychoneuroendocrinology. 2008;33(5):591–600.
MacDonald K, Feifel D. Dramatic improvement in sexual function induced by intranasal oxytocin. J Sex Med. 2012;9(5):1407–10.
Ishak WW, Berman DS, Peters A. Male anorgasmia treated with oxytocin. J Sex Med. 2008;5(4):1022–4.
Ashton AK, Hamer R, Rosen RC. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther. 1997;23(3):165–75.
Lauerma H. Successful treatment of citalopram-induced anorgasmia by cyproheptadine. Acta Psychiatr Scand. 1996;93(1):69–70.
Steele TE, Howell EF. Cyproheptadine for imipramine-induced anorgasmia. J Clin Psychopharmacol. 1986;6(5):326–7.
Sovner R. Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine. J Clin Psychopharmacol. 1984;4(3):169.
McCormick S, Olin J, Brotman AW. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry. 1990;51(9):383–4.
Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry. 1991;52(4):163–4.
Landen M, Eriksson E, Agren H, Fahlén T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 1999;19(3):268–71.
Othmer E, Othmer SC. Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder. J Clin Psychiatry. 1987;48(5):201–3.
Carro-Juareza M, Rodriguez-Manzo G. Yohimbine reverses the exhaustion of the coital reflex in spinal male rats. Behav Brain Res. 2003;141(1):43–50.
Ferraz MM, Fontanella JC, Damasceno F, Silva de Almeida OM, Ferraz MR. Chronic amantadine treatment enhances the sexual behaviour of male rats. Pharmacol Biochem Behav. 2007;86(4):616–21.
Stafford SA, Coote JH. Activation of D2-like receptors induces sympathetic climactic-like responses in male and female anaesthetised rats. Br J Pharmacol. 2006;148(4):510–6.
Lu W, Jiang W, Chen J, Yin M, Wang Z, Jiang X. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride. Int J Pharm. 2008;349(1–2):196–205.
Segraves RT. Reversal by bethanechol of imipramine-induced ejaculatory dysfunction. Am J Psychiatry. 1987;144(9):1243–4.
Melnyk J, Marcone M. Aphrodisiacs from plant and animal sources—a review of current scientific literature. Food Res Int. 2011;44:840–50.
Haberfellner EM. Sexual dysfunction caused by reboxetine. Pharmacopsychiatry. 2002;35(2):77–8.
O’Flynn R, Michael A. Reboxetine-induced spontaneous ejaculation. Br J Psychiatry. 2000;177:567–8.
Sivrioglu EY, Topaloglu VC, Sarandol A, Akkaya C, Eker SS, Kirli S. Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):548–50.
Sonksen J, Ohl DA. Penile vibratory stimulation and electroejaculation in the treatment of ejaculatory dysfunction. Int J Androl. 2002;25(6):324–32.
Sonksen J, Ohl DA, Wedemeyer G. Sphincteric events during penile vibratory ejaculation and electroejaculation in men with spinal cord injuries. J Urol. 2001;165(2):426–9.
Nelson CJ, Ahmed A, Valenzuela R, Parker M, Mulhall JP. Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm. Urology. 2007;69(3):552–5. discussion 555–6.
Gerig NE, Meacham RB, Ohl DA. Use of electroejaculation in the treatment of ejaculatory failure secondary to diabetes mellitus. Urology. 1997;49(2):239–42.
Prévinaire JG, Lecourt G, Soler JM, Denys P. Sexual disorders in men with multiple sclerosis: evaluation and management. Ann Phys Rehabil Med. 2014;57(5):329–36.
Fode M, Borre M, Ohl DA, Lichtbach J, Sønksen J. Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial. BJU Int. 2014;114(1):111–7. Demonstration of PVS for ED and neurologic causes of DE are described herein.
Fode M, Sonksen J. Penile vibratory stimulation in the treatment of post-prostatectomy incontinence: a randomized pilot study. Neurourol Urodyn. 2015;34(2):117–22.
Lieblum S, Rosen R. Principles and practice of sex therapy. 2nd ed. New York: Guilford Press; 2000.
Rowland D, van Diest S, Incrocci L, Slob AK. Psychosexual factors that differentiate men with inhibited ejaculation from men with no dysfunction or another sexual dysfunction. J Sex Med. 2005;2(3):383–9.
McCarthy BW. Strategies and techniques for the treatment of inhibited sexual desire. J Sex Marital Ther. 1984;10(2):97–104.
Perelman MA, Rowland DL. Retarded ejaculation. World J Urol. 2006;24(6):645–52.
Carvalheira A, Traeen B, Stulhofer A. Masturbation and pornography use among coupled heterosexual men with decreased sexual desire: how many roles of masturbation? J Sex Marital Ther. 2014: p. 1–10. Pornography and masturbation can lead to dissociation for men during partnered sex.
Compliance with Ethics Guidelines
Conflict of Interest
Daniel J. Sadowski and Michael J. Butcher declare no conflicts of interest.
Tobias S. Köhler declares the receipt of grants and personal fees from AMS and Coloplast and personal fees from Auxilium, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Male Sexual Dysfunction and Disorders
Appendices
Appendix 1: Treatment Algorithm for Ejaculatory Disorders
ψ = See collaboration of clinician and sexual therapist (Appendix 2).
* = Medications in Table 1 can be tried in treatment of retrograde ejaculation (see Table 1).
^ = If patient on SSRI consider use of SSRI antidote types of medications (see Table 1).
† = Medications in Table 1 can be used for prolactin abnormalities (see Table 1).
Graphic based off of Rowland et al. Please see [3].
Appendix 2: Clinician and Sexual Therapist Integrative Therapy for Delayed Ejaculation
Rights and permissions
About this article
Cite this article
Sadowski, D.J., Butcher, M.J. & Köhler, T.S. Delayed Ejaculation: Medical and Psychological Treatments and Algorithm. Curr Sex Health Rep 7, 170–179 (2015). https://doi.org/10.1007/s11930-015-0054-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11930-015-0054-x